Compare PLMR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLMR | HAE |
|---|---|---|
| Founded | 2013 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | 2019 | 1996 |
| Metric | PLMR | HAE |
|---|---|---|
| Price | $125.58 | $59.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $153.60 | $84.13 |
| AVG Volume (30 Days) | 171.4K | ★ 539.6K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.04 | 44.54 |
| EPS | ★ 7.17 | 2.46 |
| Revenue | $875,967,000.00 | ★ $910,373,000.00 |
| Revenue This Year | $192.25 | N/A |
| Revenue Next Year | $19.34 | $5.23 |
| P/E Ratio | ★ $17.64 | $24.66 |
| Revenue Growth | ★ 58.16 | N/A |
| 52 Week Low | $107.75 | $47.32 |
| 52 Week High | $175.85 | $87.32 |
| Indicator | PLMR | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 50.65 |
| Support Level | $117.39 | $48.47 |
| Resistance Level | $128.11 | $62.78 |
| Average True Range (ATR) | 4.06 | 1.88 |
| MACD | -0.55 | 0.17 |
| Stochastic Oscillator | 16.10 | 54.65 |
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.